黑料网

Immunology: Current Research
黑料网

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

黑料网 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Awards & Nominations
Publication Policies and Ethics
Citations : 64

Flyer image
Indexed In
  • Publons
  • ICMJE
View More
Useful Links
Recommended Journals
View More
Related Subjects
View More
Share This Page

Antimicrobial drug resistance (AMR)

AMR is said to be a microbe's ability to withstand the effects of medicine that could once therapize the microbe successfully. The term antibiotic resistance (AR or ABR) is an AMR exclusion because it refers only to the bacteria being antibiotic-resistant. Resistant microbes are more difficult to treat, requiring alternative medicines or higher antimicrobial doses. These can be more costly, higher risk of toxicity, or both. Numerous antimicrobial-resistant microbes are called Multidrug-Resistant (MDR). The drug resistance levels are extensively drug-resistant (XDR) and fully drug-resistant (TDR).

Antimicrobial drug resistance (AMR)

Expert PPTs

Speaker PPTs

  • Dalia Sekmokiene
    Antimicrobial, antioxidative, phytochemical and functional characteristics of the extracts of some plants and spices seeking to adapt them as a potential source of biologically active substances for the safety of dairy products
    | PDF Version
  • Sundeep Kumar Upadhyaya
    LONG TERM DRUG-FREE CLINICAL-REMISSION IN PATIENTS WITH RA ON cDMARDs
    | PDF Version
  • Li Yu-Jung
    Intra-maxillary Drug delivery and Bio-sensing via Dental Implant and its considerations
    | PDF Version
  • Miao Dong
    Isolation and characterization of novel antimicrobial peptides from Japanese medaka plasma
    | PDF Version
  • Carsten Worsoe
    The value of the 脙垄芒聜卢脜聯simulated study脙垄芒聜卢脗聺 as a tool to predict actual leachables in parenteral drug products
    | PDF Version
  • Diane Paskiet
    Qualifi cation of extractables & leachables from container closure systems in drug products- Introduction to the Product Quality Institute (PQRI) recommendations
    | PDF Version
  • Li-Chun Tsou
    Drug delivery device strategy for patient centric therapies
    | PDF Version
  • Neervalur V Raghavan
    Systematic approach to development of aqueous drug formulation and drug device combination injectable products and challenges
    | PDF Version
  • Panayiotis P Constantinides
    Parenteral Drug Nanodispersions : Manufacturing, Characterization and In Vitro/In Vivo Performance Evaluation
    | PDF Version
  • Jan Voskuil
    How antibodies can prevent medical progress and how they can be great tools?
    | PDF Version
  • Monray Edward Williams
    Molecular validation of putative antimicrobial peptides for improved Human Immunodeficiency Virus diagnostics via HIV protein p24
    | PDF Version
  • Alessandro Pini
    A novel synthetic antimicrobial peptide for the cure of gram-negative infections: Mechanism of action, efficacy in vivo, toxicity, bio-distribution and resistance selection
    | PDF Version
  • Nisreen K Aref
    To compare serum leptin levels in obese women with polycystic ovary syndrome (PCOS) and normal ovulatory obese subjects in Saudi Arabia, and to evaluate the interrelationship between leptin concentration, sex hormones, and insulin resistance.
    | PDF Version
  • Sadaf Hasan
    Standing up against antibiotic resistance with synergistic approach
    | PDF Version
  • Arshad mahmood
    TRANSPORT OF SELF-NANOEMULSIFYING DRUG DELIVERY SYSTEM (SNEDDS) ACROSS MUCUS AND CELLULAR INTERNALIZATION
    | PDF Version
  • Hugo Albrecht
    Towards pharmacological validation of MNKs as anti-cancer drug targets
    | PDF Version
  • Wei Duan
    Cancer stem cells targeted delivery of siRNA to overcome induced chemoresistance
    | PDF Version
  • Vivek Lal
    New drug development in type-2 diabetes mellitus : current and future trends 脙垄芒聜卢芒聙聹 an overview
    | PDF Version
  • Joan Smith Sonneborn
    Novel anti-retroviral drug targets: Interfering siRNA and mitochondrial TERT expression
    | PDF Version
  • Barbara Klajnert-Maculewicz
    Sugar-modified PPI dendrimers as carriers of anti-leukemia drugs
    | PDF Version
  • Adel Nefzi
    脙垄芒聜卢脜聯Adel Nefzi-Torrey-Pines-Institute-for-Molecular-Studies-USA-Diversity-Oriented-Synthesis-of-low-Molecular-Weight-Acyclic-and-Heterocyclic-Compounds-from-Resin-bound-Polyamides-Application-for-Drug-Discovery脙垄芒聜卢脗聺
    | PDF Version
  • Tanvir Ahmed
    Sexual partners and condom use attitude: Qualitative findings among injecting drug users in Hai Phong, Vietnam
    | PDF Version
  • Pierre Moine
    Systemic Antimicrobial Prophylaxis Issues
    | PDF Version
  • Mukesh Kumar
    Membrane fusion mediated cytosolic drug delivery through scFv targeted Sendai viral envelopes
    | PDF Version
  • Thomas J Franz
    Assessing the BA and BE of Topical Dermatologic Drug Products with Multiple Surrogate Methods
    | PDF Version
  • Rinat Islamov
    Pharmacokinetics (PK) of anti-tuberculosis drug (FS-1) on healthy volunteers: results from the phase I trial
    | PDF Version
  • Almas Okassov
    Chemical modification of anticancer Parasporins for decreasing of their toxicity
    | PDF Version
  • Habil Andras Fodor
    Plant medicine and veterinary potential of antimicrobial peptides produced by entomopathogenic nematode symbiotic bacteria
    | PDF Version
  • Akujobi Comfort
    Multi drug-resistant tuberculosis (MDR-TB) among HIV positive patients in a tertiary institution in south eastern Nigeria
    | PDF Version
  • Marco Manfredi
    Primary antimicrobial susceptibility changes in children with Helicobacter pylori infection over 13 years in northern Italy
    | PDF Version
  • Sevgi Gungor
    Micelles as nanosized carriers for skin delivery of drugs
    | PDF Version
  • Ru Band Lu
    Anti-Inflammation and neuroprotective drugs benefit the treatment of heroin dependent patients
    | PDF Version
  • Helmi Mardassi
    A ten-year evolution of a multidrug-resistant tuberculosis (MDR-TB) outbreak in an HIV-negative context, Tunisia (2001-2011)
    | PDF Version
  • D J Kalita
    Antibiotic resistance and strategies to develop new antibiotics
    | PDF Version
  • Sungchul Ji
    Mathematical Models of RNA Expression Profiles: Potential Applications to Drug Discovery Research and Personalized Medicine
    | PDF Version
  • Anita Nair
    BCS-Based Biowaivers: Which Drugs are Eligible?
    | PDF Version
  • Adriana Katz
    Na,K-ATPase isoform-selective cardiac glycosides- a potential anti-cancer drug ?
    | PDF Version
  • Eggehard Holler
    Biodegradable nanobrushes for drug delivery
    | PDF Version
  • Robert Engel
    Antimicrobial surfaces
    | PDF Version
  • Bharati N Bhat
    Identification of sources of resistance against Fusarium Wilt of Castor
    | PDF Version
  • R Gandhi Gracy
    DO Insect - Bacterial Symbiosis contributing insecticidal resistance: An evidence from Helicoverpa armigera (Hub.) (Lepidoptera: Noctuidae)
    | PDF Version
  • Kevin B Strychar
    Climate change, disease and pathogen resistance (immunity) in coral
    | PDF Version
  • Tao Lu
    Using VBIM technique to identify drug resistance genes in ovarian cancer
    | PDF Version
  • Navneet Sharma
    Transdermal patches based on solid lipid nanoparticles of Metformin: Novel approach for drug delivery of Type 2 diabetes
    | PDF Version
  • Viral Kansara
    Ocular melanin modulates pharmacokinetics and drug disposition of therapeutic agents
    | PDF Version
  • Richard A. Kenley
    Equilibrium binding interactions between lotrafilcon a soft contact lenses and the two prostaglandin anti-glaucoma drugs Bimatoprost and Tafluprost
    | PDF Version
  • Elena Gavrilova
    Application of drugs based on release-active antibodies as immunotherapy agents
    | PDF Version
  • William Lee
    Regulatory roadmap for initiating a cell therapy drug into clinical trials in the US
    | PDF Version
  • Krasimira Pekova
    Have FDA expedited programs really shortened drug review time? an analysis of newly approved therapies and how FDA expedited programs have impacted drug development timelines
    | PDF Version
  • Jasmin Kaur
    Helping clinicians connect: Understanding addiction from the perspective of a drug abuser
    | PDF Version
  • Matin Peters
    Cognitive-behavioral therapy as an effective treatment method in the ASEAN setting
    | PDF Version
  • Marcelo Febo
    3,4-Methylenedioxypyrovalerone (MDPV), a major bath salt drug, reduces functional connectivity in rat brain
    | PDF Version
  • Jim Klostergaard
    Magnetic vectoring for drug delivery to tumors: Past, present and is there a future?
    | PDF Version
  • John Tsaknis
    Antioxidant and antimicrobial activity of Chios mastic gum fractions (neutral, acidic) before and after encapsulation in liposomes
    | PDF Version
  • Sree Harsha
    Optimization of particles size for lung specific drug delivery by way of microspheres
    | PDF Version
  • Mauro Comes Franchini
    Gold, silver magnesium and magnetic nanoparticles: Nanomedicine applications in drug delivery
    | PDF Version
  • W Wagner
    Tumor regression by means of magnetic drug targeting
    | PDF Version
  • Jung-Joon Min
    Bacteria-mediated expression of cargo drugs and reporter gene for cancer-specific theranostics
    | PDF Version
  • Maria Paola COSTI
    A proteomic-bioinformatic integrated approach for studying the effect of a peptide drug candidate on ovarian Cancer
    | PDF Version
  • Vladimir Torchilin
    Stimuli-sensitive combination nanopreparations of siRNA and chemotherapeutic drugs to treat multidrug resistant cancer
    | PDF Version
  • Etienne Dako
    Antimicrobial effects of capsaicinoids and lecithin on the growth of food borne pathogenic bacteria
    | PDF Version
  • Baharudin Ibrahim
    Personalizing drug treatment using pharmacometabonomic approach
    | PDF Version
  • Tahsin Shoala
    Oxi1 mutant plays an important role in Arabidopsis resistance against aphid (Myzus persicae)
    | PDF Version
  • Dilek Heperkan
    Antimicrobial activity of lactic acid bacteria on pathogens in foods
    | PDF Version
  • Ruben Artero
    A Drosophila high-throughput drug screening platform identifies inhibitors of misregulated alternative splicing events in myotonic dystrophy
    | PDF Version
  • Vladimir E. Bondarenko
    Mathematical model of 脙聨脗虏1-adrenergic signaling in mouse ventricular myocytes as an in silico tool for the cardiovascular drug test
    | PDF Version
  • Maria ISAGULIANTS
    DNA vaccination against drug resistance in chronic viral infections, example of HIV-1
    | PDF Version
  • Grace London
    Development of aptamer based HIV-1 entry inhibitor prophylactic drugs
    | PDF Version
  • Maria Teresa Mascellino
    Candida bloodstream infections: species distribution and antifungal resistance in General Medicine wards and in Intensive Care Units (ICUs)
    | PDF Version
  • Aina Westrheim Ravna
    Novel sildenafil analogues: possible drugs for increased sensitivity to chemotherapeutic agents
    | PDF Version
Conference Proceedings